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Many authors have entertained the possibility, mainly on epidemiological grounds, 
that multiple sclerosis is a consequence of a disease  acquired in childhood (1).  Among 
the number of common childhood infectious agents that have been impliacted in this 
disease,  viral agents, in particular the paramyxoviruses, cccupy a prominent place as 
possible etiological agents. First, a number of studies have demonstrated that both the 
sera and cerebrospinal fluid of multiple sclerosis patients contain unusually high titers 
of measles antibody (2-4). Secondly, at least two investigators have reported either 
isolation of paramyxoviruses or the presence of viral nucleocapsids in the brains  of 
patients with multiple sclerosis  (5, 6). Finally, pathological examination of the brains 
of experimental animals infected with viruses such as canine distemper virus, a virus 
related to human measles virus, may occasionally cause demyelination of the canine 
brain tissue (7). 
In spite of these reports relatively little attention has been paid to the state of 
the  cellular immunity  to these viral  agents in multiple  sclerosis patients  (8). 
Because  of these  findings  we were  encouraged to  reexamine  the  question  of 
cellular immunity to viral antigens in patients with multiple sclerosis. Particu- 
lar  attention  was  placed  on  the  cellular  reactivity  to  a  group  of paramyxo- 
viruses known to cause childhood infections. Using the method of direct migra- 
tion inhibition of peripheral  blood leukocytes in the presence of a  given sensi- 
tizing  antigen,  the  present  study  demonstrates  that  patients  with  multiple 
sclerosis  have  a  specific  lack  of cellular  recognition  for measles  antigens  yet 
maintain a  normal cellular response to both parainfluenza and rubella viruses. 
These studies were presented  as part  of the Multiple  Sclerosis  Symposium at 
the  Tenth  International  Congress  of Neurology in  Barcelona,  Spain,  on  11 
September,  1973. 
Materials and Methods 
Subjects.--15 patients with multiple sclerosis in various stages of the disease were age and 
sex matched with an equal number of controls. The patients  were also matched as nearly as 
possible as to the place of birth with the control subjects. 
Laboratory Methods.--The method  of  direct  migration  inhibition  of  peripheral  blood 
leukocytes as originally described by Bendixen (9) and modified by Zabriskie et al. (10) was 
used in all experiments. This  method  may be briefly described as follows: 30 ce of whole 
venous blood were drawn  by syringe and placed in heparinized vacutainer  tubes  (Becton- 
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Dickinson and Co., Rutherford, N. J.). The blood was mixed in these tubes with a solution of 
2% Knox gelatin in 0.85% saline, and sedimented at 37°C at 45 ° slant for 15 min and upright 
for 5 min. The leukocyte-rich plasma and gelatin supernatant is removed and spun down at 
700 g for 10  min. The pellet is treated with ammonium chloride for 5-10 rain  to lyse the 
remaining erythrocytes; the leukocytes are then washed three times in saline,  and concen- 
trated in tissue culture medium (Eagle's-Earle's balanced salt solution with added vitamins 
and amino acids and 20% fetal calf serum [Flow Laboratories, Rockville, Md.]) to 20  )<  107 
lymphocytes per cc.  Aliquots of this leukocyte suspension are loaded into 20-~l  capillaries, 
the bottom of the capillaries is sealed with clay, and the capillaries are spun down at 300 g 
for 10 min. The capillaries are cut at the medium-cell  interface, and the pieces containing the 
pellet are placed in planchettes (York  Scientific,  Ogdensburg, N.  Y.)  to which appropriate 
concentrations of antigens are added. The planchettes are covered with glass cover slips sealed 
on with stopcock grease and incubated at 37°C for 18 h. All tests are done in triplicate. The 
resultant fans are projected on tracing paper; these projections are cut out and weighed. The 
migration index is calculated as previously  described (11). 
Antigens.--All  the antigens were obtained from Flow  Laboratories. The  measles virus 
(lot no. M944034)  is  the Edmonston 84F strain, final passage being in a  primary African 
Green monkey kidney culture with BME  (Earle's salts)  and 2% fetal bovine serum. The 
activated antigen preparation is prepared by freeze-thawing  of virus infected cells, followed by 
sonication of the disrupted cells and finally mild centrifugation to remove large cellular debris. 
The supernatant fluid  containing measles antigens is used in the test system. Type 1 pars- 
influenza antigen (lot no. E921036)  is from the Sendai strain and is grown in embryonated 
hens' eggs (allantoic fluid). The rubella antigen was prepared as an alkaline extract of rubella 
(Gllchrist)-infected BHK-21  (C/13) cell cultures and reconstituted in the medium  described 
above (Flow Laboratories). Lots nos. L960133 and C961207 were used. None of the antigens 
contain preservatives and are stored at -60°C until use. They are diluted to the appropriate 
concentrations immediately before use.  Control antigens (i.e.,  supernatants from the appro- 
priate tissue culture lines but without virus, were also provided by Flow Laboratories)  are 
treated in the same way as the viral antigens. These antigens were added to the medium in the 
appropriate concentrations to create the control fans. 
RESULTS 
The  results  of  the migrations  are shown on  the  accompanying graph  (see 
Fig.  1).  Cellular  sensitivity  is  presumed  to  exist  if  the  migration  inhibition 
index  is greater  than  15 %.  The mean direct  migration inhibition  to measles 
antigen in the patients with multiple sclerosis was 21.3 %( SE  =  4-6.7 %)  at a 
1:10  dilution  and  1.9%  (SE  =  4-4.2%)  at  1:100  dilution  of  the antigen  in 
medium. These values are significantly different  (P  <  0.001)  from the means 
obtained  to  the  same antigen  dilutions  in  the  normal age-  and  sex-matched 
controls (48.7 %, SE --  4-4.8%  and 26.3 %, SE  =  4-6.2, respectively). 
On the other hand, no significant differences were found between patients and 
controls with either rubella antigens or with parainfluenza type 1 antigen. The 
mean direct inhibition to rubella antigen diluted 1:40 for patients with multiple 
sclerosis is 22%  (SE  =  4-6.8%)  and for controls 18%  (SE  =  4-5.8%)  (P  > 
0.7).  The  mean  direct  inhibition  to  parainfluenza  type  1  antigen  was  33% 
(SE  =  4-5.6%)  for patients  and  26%  (SE  =  4-7.8%)  for controls at  1:10 
dilution  (P  >  0.5)  and 30%  (SE  =  +6.8%)  for patients  and  30%  (SE  = 
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FIG. 1. A comparison  of the migration inhibition values to viral antigens in patients with 
multiple sclerosis and normal subjects. Note the marked absence of cellular reactivity to 
measles antigens in multiple sclerosis  patients as compared  with the controls. 
Studies with a human brain homogenate in a number of these patients further 
support our observation that patients  with multiple  sclerosis have a  loss of 
cellular reactivity that is specific for measles antigens:  at several concentra- 
tions of brain antigens  (100,  10, and 1/~1) there was no significant difference 
(P  >  0.3 and  <0.5)  in the degree of cellular reactivity to these antigens in 
multiple  sclerosis  patients  and  normal  control  subjects  (31.0%  4-  8.1  for 
multiple sclerosis and 20.0% 4- 7.2 for normal subjects). 
While it is admitted that a number of patients in the study were on steroid 
therapy, these patients did not exhibit a general depression of cellular immunity 
since  their  response  to  other viral  antigens,  as  well  as  brain  antigens,  was 
similar to that observed with normal control subjects. 
In view of lack of cellular response to measles antigen, it was of interest to 
determine whether this cellular energy could be reversed in vitro by the use of 
transfer factor obtained from subjects with normal cellular response to measles 
antigen.  Indeed, previous studies in  this laboratory have demonstrated that 
transfer from purified protein derivative (PPD)  skin test-positive individuals 
will markedly enhance the in vitro degree of inhibition of cells obtained from 
individuals who are PPD skin test negative (11). Accordingly, transfer factor 
(12) prepared from subjects with an unusually good cellular response to measles 
antigen (> 60% inhibition) was incorporated into the medium in which leuko. 
cytes from multiple sclerosis patients migrated. In a total of five patients tested 
to date,  there was  an increase of migration inhibition index of 10-20%,  the 
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factor alone had no effect on the migrating cells and, as expected, the incorpora- 
tion  of measles antigen in  the medium without  transfer factor gave results 
similar to that observed on the initial testing of these patients. 
DISCUSSION 
Suppression  of cellular reactivity to measles antigen demonstrated in this 
test system by patients with multiple sclerosis  contrasts sharply with these 
patients' normal cellular reactivity to the other viral antigens used, notably 
parainfluenza type 1 and rubella virus. Of particular interest was the fact that 
these patients react normally to the parainfluenza type 1 virus (Sendal) since 
this  virus  has  been  isolated from the  brains  of  two patients  with multiple 
sclerosis  (5). However, it must be emphasized that Ter Meulen and Koprowski 
maintain that this virus differs in a number of biological characteristics from 
the parainfluenza virus used in our studies. This suppression of cellular reac- 
tivity to measles antigen is particularly remarkable in light of the increased 
measles antibody titers said to be present in this disease, and would suggest that 
measles virus, or an agent antigenically very" similar to it, may be important in 
the pathogenesis of multiple sclerosis. There are at least two possible explana- 
tions for our findings: 
(a)  During the initial measles infection the clone of cells reacting to measles 
antigen has been wiped out, resulting in suppressed cellular response to measles 
virus. This anergy could permit persistence of the measles virus in the central 
nervous system and ongoing latent infection affecting the astrocyte population. 
As the astrocytes are essential to the integrity of the myelin sheath (7),  such 
persistent viral infection would result in patchy demyelinization and the clini- 
cal picture of multiple sclerosis. 
(b)  Due  to  a  genetically determined abnormal immune response,  patients 
with multiple sclerosis  are unable to make an effective antibody against the 
measles virus, with resultant persistence of the infection in the central nervous 
system. As  the virus  remains,  the patient  is  stimulated to  make ineffective 
antibody continuously. These high antibody titers of measles antibody (hu- 
moral immunity) may, in a manner not yet completely understood, suppresses 
cellular reactivity (cellular immunity) to this viral antigen. In support of this 
hypothesis are numerous observations that suggest that high humoral immunity 
results in poor cellular response to a given antigen (13, Paterson, P. Y., personal 
communication). In addition, patients with multiple sclerosis have an increased 
incidence of HL-A 3,7 histocompatibility markers, thereby providing evidence 
for a possible genetic predisposition to disease (14). 
While we find cellular suppression only to measles antigen at present, it must 
be admitted that only three viral antigens were tested.  A  larger number of 
viral antigens will have to be tested before we can be absolutely sure this cellu- 
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If indeed this cellular anergy to measles is a phenomenon of basic importance 
in multiple sclerosis, it was of major interest to see whether this phenomenon 
could be reversed in vitro. Our preliminary experiments using transfer factor 
from measles-immunocompetent individuals to transfer immunocompetence to 
measles-anergic individuals  (multiple sclerosis patients)  have been  successful 
and suggest that anergy to measles antigen may also be reversed in vivo. The 
findings described in this paper may provide both a  rationale for this kind of 
therapy  and  a  means  of following--by direct  migration  inhibition--in  vitro 
parameters of the effect of such therapy. These studies are now in progress. 
REFERENCES 
1.  Multiple Sclerosis Progress in Research. 1972. E. J. Field,  J. M. Bell, and P. R. 
Carnegie,  editors.  North Holland Publishing Co., Amsterdam. 177-230. 
2.  Adams, J. M., and D. T. Imagawa. 1962. Measles antibodies in multiple sclerosis. 
Proc. Soc. Exp. Biol. Med. 111:562. 
3.  Panelius,  M., A. Salmi, P. Halonen, E. Kivalo, U. K. Rinne, and K. Penttinen. 
1972. Virus antibodies in sera of patients with multiple sclerosis,  in controls 
matched for age, sex and place of residence, and in siblings. In Multiple Sclerosis 
Progress in Research. E. J. Field, J. M. Bell, and P. R. Carnegie, editors.  North 
Holland Publishing Co., Amsterdam. 3. 
4.  Brown, P., F. Cathala, D. C. Gajdusek, and C. J. Gibbs. 1971. Measles antibodies 
in the cerebrospinal fluid  of patients with multiple sclerosis. Proc. Soc.  Exp. 
Biol. Med. 137:956. 
5.  Ter Meulen, V., H. Koprowski, Y. Iwasaki, Y. M. K~tckell, and D. Mfiller.  1972. 
Fusion of cultured multiple sclerosis brain cells with indicator cells: presence of 
nucleocupsids  and  virions and  isolation  of parainfluenza-type virus.  Lancet. 
2:1. 
6.  Prineas, J. 1972. Paramyxovirus-like partiicles associated with acute  demyelina- 
fion in chronic relapsing multiple sclerosis. Science (Wash. D. C.). 178:760. 
7.  Raine, C. S. 1972. Viral infections  of nervous tissue and their relevance to multi- 
ple sclerosis. In Multiple Sclerosis. Immunology, Virology, and Ultrastructure. 
F. Wolfgram, G. W. Ellison,  J. C. Stevens,  and J. M. Andrews,  editors.  Aca- 
demic Press, Inc., New York. 91. 
8.  Rocklin, R. R. 1972. What is the role of the lymphocyte in multiple sclerosis? In 
Multiple Sclerosis. Immunology, Virology, and Ultrastructure. F. Wolfgram, G. 
W. Ellison,  J. C. Stevens,  and J. M. Andrews,  editors.  Academic Press, Inc., 
New York. 365. 
9.  Bendixen,  G.  1967. Specific inhibition of the in vitro  migration of leucocytes in 
ulcerative colitis and Crohn's disease. Scand. J. Gastroenterol. 9.:214. 
10.  Zabriskie, J. B., R. Lewshenia,  G. Mtiller, B. Wehle, and R. E. Falk. 1970. Lym- 
phocytic  responses  to  streptococcal antigens  in  glomerulonephritis patients. 
Science (Wash. D. C.). 168:1105. 1596  UTERMOHLEN  AND ZABRISKIE  BRIEF  DEFINITIVE REPORT 
11.  Read, S. E., and J. B. Zabriskie.  1972. Cellular interactions in the leukocyte mi- 
gration inhibition system. Transplant.  Proc. 4:247. 
12.  Lawrence, H.  S.,  and  S.  A1-Askari.  1971.  The  preparation  and  purification  of 
transfer factor. In In Vitro Methods in Cell-Mediated Immunity. B. R. Bloom 
and P. R. Glade, Editors. Academic Press, Inc. New York. 531. 
13.  Derick, C. L., C. H. Hitchcock, and H. F. Swift.  1930. Reactions to nonhemolytic 
streptococci. III. A study of modes of sensitization. Y. Exp. Med. 52:1. 
14.  Bertrams, J., and E. Kuwert. 1972. HL-A antigen frequences in multiple sclerosis. 
Fur. Neurol. 7:74. 